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tember 10, 2013.his study sought to determine if an integrated healthcare system is selective and consistent in the use of
angiography, as reﬂected by normal coronary rates.Background Rates of normal coronary arteries with elective coronary angiography vary considerably among U.S. community
hospitals. This variation may in part reﬂect incentives in fee-for-service care.Methods Using national data from the Veterans Affairs (VA) Clinical Assessment Reporting and Tracking (CART) program
representing all 76 VA cardiac catheterization laboratories, we evaluated all patients who underwent elective
coronary angiography from October 2007 to September 2010. Normal coronary angiography was deﬁned as <20%
stenosis in all vessels. To assess hospital-level variation in normal coronary rates, we categorized hospitals by
quartiles as deﬁned by their proportion of normal coronaries.Results Overall, 4,829 of 22,538 patients (21.4%) had normal coronary angiography. Hospital proportions of normal
coronaries varied markedly (median hospital proportion 20.5%; interquartile range: 15.1% to 25.3%; range: 5.5% to
48.5%). Categorized as hospital quartiles, the median proportion of normal coronaries in the lowest quartile was
10.8%, as compared with a median proportion of 19.1% in the second lowest quartile, 23.1% in the second highest
quartile, and 30.3% in the highest quartile. Hospitals with lower rates of normal coronaries had higher rates of
obstructive coronary disease (59.2% vs. 51.3% vs. 52.6% vs. 44.3%; p < 0.001) and subsequent revascularization
(38.1% vs. 33.9% vs. 31.5% vs. 29.3%; p < 0.001).Conclusions Approximately 1 in 5 patients undergoing elective coronary angiography in the VA had normal coronaries. This rate is
lower than prior published studies in other systems. However, the observed hospital-level variation in normal
coronary rates suggests opportunities to improve patient selection for diagnostic coronary angiography.
(J Am Coll Cardiol 2014;63:417–26) ª 2014 by the American College of Cardiology FoundationCoronary angiography has an important role in the diagnosis
of coronary artery disease (CAD). Proper patient selection to
avoid unnecessary procedural risk and cost of angiography is
critical to high-quality care (1,2). To this end, rates of
normal coronary angiography have been used as an indirect
measure of the quality of patient selection, given that use inSchool of Medicine, Aurora, Colorado; yVA
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; revised manuscript received August 22, 2013,patients with a low likelihood of CAD results in higher rates
of angiographic normal coronaries (3,4). Recent studies
found that 39% of patients undergoing elective angiography
in the United States have normal coronaries, with some
centers reporting rates in excess of 70% (5,6).See page 427One possible contributor to the variable rates of normal
coronaries at angiography may be incentives in U.S. health-
care delivery. Both the fragmented, noncoordinated organi-
zation of cardiac care and a fee-for-service reimbursement
model for cardiac procedures may incent procedural overuse
(7–9). It is possible that healthcare systems with integrated
organization and non fee-for-service reimbursement models,
such as the Veterans Affairs (VA) healthcare system, may be
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418more selective and consistent in
the use of diagnostic angiog-
raphy, as reﬂected by a lower
overall rate of normal coronaries
and less variation in this rate
between VA facilities. To date,
little is known about coronary
artery rates with coronary angi-
ography in integrated healthcare
systems such as the VA.
Accordingly, we measured the
rate of normal coronaries among
patients undergoing elective diag-
nostic coronary angiography in
theVAhealthcare system, and the
variability in this rate among VA
hospitals nationally. Furthermore,as pre-procedural Framingham risk scores and stress testing
reﬂect the likelihood of CAD and are thus measures of
patient selection, we determined the association between
pre-procedural measures and hospital rates of normal coro-
naries. Finally, to ensure that variation in normal coronary
rates was attributable to patient selection rather than
differences in angiographic reporting, we applied alternative
thresholds of coronary stenosis in assessing facility-level
variation and evaluated revascularization rates in follow-up
from the index procedure.Methods
Data source. The VA Clinical Assessment Reporting and
Tracking (CART) program is a national clinical quality
program for VA catheter laboratories. The CART program
uses a software application embedded in the VA electronic
health record (EHR) for medical record documentation of
catheter laboratory procedures to collect key patient and
procedural data on all coronary procedures conducted in the
76 VA catheter laboratories nationwide. This data is then
linked to the VA EHR, allowing for linkage to longitudinal
mortality, hospitalization, outpatient visit, medication, and
laboratory data. In addition, the CART data is linked to the
Centers for Medicare and Medicaid Services (CMS) and
fee-based data to determine hospitalization for veterans who
receive CMS-sponsored care or non-VA care when the VA
pays for the veterans’ care.
Data elements in the CART application are standardized
and based on the American College of Cardiology’s National
Cardiovascular Data Registry (NCDR) (10). A dedicated
staff provides continuous monitoring, maintenance, and
updating of the application. Quality checks of the CART
data are periodically conducted for completeness and accu-
racy. Additional details on CART and the validity,
completeness, and timeliness of the CART data have been
previously described (11–13).
Study population. We evaluated all veterans undergoing
coronary angiography in the VA system between October 1,2007, and September 30, 2010. To identify those patients
undergoing elective angiography, we excluded patients with
emergent or urgent indications for coronary angiography
(acute coronary syndromes, acute myocardial infarction, or
cardiogenic shock) and coronary angiography performed in
consideration of transplantation, valvular surgery, or other
preoperative evaluation, cardiomyopathy/heart failure eval-
uations, cardiac tamponade, congenital heart disease, or
research studies. To enhance the comparability of our pop-
ulation with prior studies, we also excluded patients with
a prior history of myocardial infarction, percutaneous coro-
nary intervention, coronary-artery bypass surgery, cardiac
transplantation, or valvular surgery (5,6). Finally, to avoid
inﬂation of variation in hospital normal coronary rates due to
small procedural volumes, we excluded facilities performing
fewer than 50 elective diagnostic angiograms annually.
We assessed patient demographics, clinical risk factors,
Framingham risk score, pre-procedural stress testing prior to
angiography, indication for diagnostic angiography, angio-
graphic ﬁndings, and revascularization within 90 days of the
index angiogram. Framingham risk scores were calculated
using patient demographics, blood pressure at presentation,
and cholesterol data obtained within 6 months prior to
angiography (14). For patients with missing cholesterol data
(<10%), data was imputed using multivariate sequential
regression (IVEware) (15). Framingham scores were cate-
gorized by 10-year coronary heart disease risk (<10% low;
10% to 20% intermediate;>20% high) (2,16). Pre-procedural
stress testing was determined by either patient data from the
CART program or VA EHR data documenting a stress test
performed in the preceding 90 days. Tests included exercise
treadmill testing, stress echocardiography, or stress nuclear
perfusion testing, and results were categorized as positive,
negative, equivocal, or unknown by provider documentation
in the CART pre-procedural assessment. Procedural indica-
tion was determined from structured data ﬁelds in the CART
pre-procedural assessment.
Angiographic ﬁndings were determined from CART
procedure reports. Consistent with prior studies, patients
with normal coronaries were deﬁned by angiographic ﬁnd-
ings with stenosis less than 20% in all vessels from coronary
segment speciﬁc data and normal coronaries by summary
descriptive data (5). Nonobstructive CAD was deﬁned
as <50% stenosis in the left main coronary and <70%
stenosis in all other coronary vessels. Obstructive CAD was
deﬁned as stenosis of 50% in the left main coronary artery
or any stenosis 70% in any other coronary vessel. Revas-
cularization (either percutaneous coronary intervention or
coronary artery bypass) within 90 days of the index angio-
gram was determined from both VA and non-VA sources as
previously described.
Hospital characteristics and deﬁnitions. Hospital char-
acteristics were collected from the CART program and the
Veterans Health Administration Support Service Center.
We evaluated for relationships between a hospital’s normal
coronary rate and hospital-level factors such as hospital size
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419(number of inpatient beds), procedural volume, presence of
an on-site coronary artery bypass surgery program, teaching
facility, and geographic location using Veteran Integrated
Service Networks aggregated to larger geographic regions
based on the best overlapping boundaries with U.S. census
regions (17).
Statistical analysis. We measured the proportion of
patients undergoing angiography with normal coronaries
and compared their demographics, clinical characteristics,
Framingham risk scores, pre-procedural stress testing ﬁnd-
ings, and indications for angiography with patients found to
have CAD at angiography. Comparisons were conducted
using chi-square tests for categorical variables and
nonparametric tests for continuous variables.
To assess hospital variation in normal coronary rates, we
determined hospital-level proportions of patients with
normal coronaries. We compared patient and hospital-level
characteristics across quartiles of hospitals as deﬁned by
their proportion of normal coronaries, using linear regression
for continuous variables and Cochran-Armitage trend test
for categorical variables.
Although rates of normal coronaries have been proposed
as an indirect quality measure of patient selection, there may
be variability in reporting of normal rates, given the potential
implications of luminal irregularities on CAD risk. To
ensure hospital variation in normal coronary rates was
predominantly attributable to differences in patient selection
rather than differences in reporting of stenosis severity, we
assessed the impact of varying thresholds of stenosis severity
(i.e., normal vs. nonobstructive) on hospital-level variation
in angiographic ﬁndings. Furthermore, we compared rates
of obstructive CAD and subsequent revascularization by
hospital quartiles of normal coronaries. Finally, to ensure our
ﬁndings were not inﬂuenced by variation in facility-level
procedural volume and inclusion of procedures with
“unknown” clinical indication, we graphed facility-level rates
of normal coronaries against facility level procedural volume
and repeated our primary analysis after inclusion of patients
with unknown procedural indication.
All tests for statistical signiﬁcance were 2-tailed and
evaluated at a signiﬁcance level of p < 0.05. All statistical
analyses were performed by the CART Coordinating Center
at the Denver VA Medical Center using SAS version 9.2
(SAS Institute Inc., Cary, North Carolina). The study was
approved by the Colorado Multiple Institutional Review
Board.Results
Study population. From October 1, 2007, through
September 30, 2010, there were 90,703 patients who un-
derwent diagnostic coronary angiography at one of the
76 VA cardiac catheterization laboratories and had proce-
dural data recorded by the CART program. After excluding
42,440 patients (46.8%) with a prior history of cardiac
disease, 12,728 patients (14.0%) with urgent or emergentindications for coronary angiography, 11,528 patients
(12.7%) with other indications for diagnostic catheterization,
883 patients (1.0%) with unknown angiographic results, and
586 patients (0.6%) from 10 low-volume facilities, our study
cohort consisted of 22,538 patients at 66 VA cardiac cath-
eterization laboratories (Fig. 1).
Baseline patient characteristics by coronary angiographic
results. Overall, of 22,538 patients undergoing elective
coronary angiography, 4,829 patients (21.4%) had normal
coronary angiography. Compared with patients who had
angiographic CAD, the patients who had normal coronaries
were younger and more often female or nonwhite (Table 1).
Patients with normal coronaries were less likely to have
cardiovascular risk factors of hypertension, hyperlipidemia,
diabetes, history of smoking, peripheral vascular disease, or
cerebrovascular disease in comparison with CAD patients.
Differences in cardiovascular risk were also evident from the
distribution of Framingham risk scores, with normal coro-
nary patients being more likely to have low risk scores
(37.5% vs. 16.7%) and less likely to have high risk scores
(21.9% vs. 42.8%). Patients with normal coronaries were less
likely to have received a pre-procedural stress test (70.3% vs.
76.3%). Comparisons of pre-procedural stress testing results
were complicated by the lack of detailed results for a large
proportion of patients (44.1% vs. 45.2%). A procedural
indication of chest pain was more common among patients
with normal coronaries (66.2% vs. 62.9%), whereas an
evaluation for ischemic heart disease (2.4% vs. 12.2%) or
a positive stress test (60.1% vs. 65.8%) was less common in
patients with normal coronaries. Among patients with
angiographic evidence of coronary disease, 11,622 (65.6%)
had obstructive CAD.
Hospital variation in normal coronary rates. The median
hospital proportion of patients with normal coronaries was
20.5%, with a range from 5.5% to 48.5% (Fig. 2). Catego-
rized as hospital quartiles, the median proportion of normal
coronaries in the lowest quartile was 10.8%, as compared
with a median proportion of 19.1% in the second lowest
quartile, 23.1% in the second highest quartile, and 30.3% in
the highest quartile (Table 2). There were no notable trends
in patient demographics, cardiovascular risk factors, or
Framingham risk scores by hospital quartile of normal
coronaries. Patients at hospitals with lower normal coronary
rates were more likely to undergo stress testing prior to
angiography compared with higher normal coronary rate
hospitals (79.5% vs. 77.5% vs. 77.5% vs. 65.6%; p < 0.001
for trend). Comparisons of noninvasive test results by
hospital quartile were complicated by differential rates in
unknown stress test results. The indication for angiography
at hospitals with lower normal coronary rates more
frequently included a positive functional study (67.0% vs.
66.6% vs. 64.4% vs. 59.7%; p < 0.001) or evaluation of
possible ischemic heart disease (15.1% vs. 10.4% vs. 7.7% vs.
10.6%; p < 0.001). Rates of obstructive CAD were higher at
hospitals with lower rates of normal coronaries (59.2% vs.
51.3% vs. 52.6% vs. 44.3%; p < 0.001), as were rates of
Figure 1 Identiﬁcation of VA Elective Diagnostic Coronary Angiography Cohort
We identiﬁed 22,538 patients who underwent elective coronary angiography at 66 Veterans Affairs (VA) hospitals. ACS ¼ acute coronary syndrome(s); CABG ¼ coronary artery
bypass graft; MI ¼ myocardial infarction; PCI ¼ percutaneous coronary intervention.
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420subsequent revascularization (38.1% vs. 33.9% vs. 31.5% vs.
29.3%; p < 0.001). Furthermore, hospital rates of normal
coronaries were associated with rates of nonobstructive
disease (Pearson rho ¼ 0.63; p < 0.001) (Fig. 3A).
However, changing the threshold of interest for coronary
stenosis resulted in differences in the ranked distribution of
hospital-level variation in angiographic ﬁndings (Fig. 3B).
Although the ranked distribution was correlated (Spearman
rho ¼ 0.53; p < 0.001), using nonobstructive coronary rates
rather than normal coronary rates improved the hospital-
rank by at least 25% for 12 hospitals (18.2%) and wors-
ened the hospital-rank by at least 25% for 13 hospitals
(19.7%). There were no signiﬁcant differences in hospital
characteristics by quartile of normal coronary rates (Table 3).
Sensitivity analyses demonstrated variation in facility-level
rates of normal coronaries was not inﬂuenced by facility
procedural volume or by the inclusion of procedures with
unknown clinical indication (Online Appendix).
Discussion
We sought to determine the rate of normal coronaries
among patients undergoing elective diagnostic coronary
angiography in the VA healthcare system, the variability
in this rate among VA hospitals nationally, and the associ-
ated variation in select pre-procedural measures of patient
selection for coronary angiography. Among more than22,500 patients undergoing elective coronary angiography at
66 VA hospitals, 21% had normal coronaries. We observed
marked hospital level variation in normal coronary rates,
ranging from 5.5% to 48.5%, with higher rate hospitals
having less use of pre-procedural stress testing. Furthermore,
hospitals with higher rates of normal coronaries had lower
rates of obstructive CAD and subsequent revascularization.
The observation of hospital-level variation in normal coro-
nary rates suggests an opportunity to improve patient
selection for diagnostic coronary angiography in the VA.
In a prior study using data from the NCDR, in which
90% of hospitals were categorized as private or community
hospitals, 39% of patients undergoing diagnostic coronary
angiography had normal coronaries (5). The lower rate of
normal coronaries at VA hospitals, coupled with a preva-
lence of high Framingham risk that was twice that observed
within NCDR, suggests a higher threshold for patient
selection to undergo angiography in the VA compared with
other U.S. populations. This is further suggested by
a recent study comparing rates of obstructive CAD among
patients undergoing elective angiography in Ontario,
Canada, and New York State. Within the government-
funded single-payer system of Ontario, the rate of
obstructive CAD was nearly 15% higher than in New York
State. Furthermore, the pretest probability of CAD among
patients undergoing angiography was higher among pa-
tients in Ontario.
Table 1 Patient Characteristics by Diagnostic Coronary Angiography Results
Characteristic
All Patients
(n ¼ 22,538)
Angiographic Results
p Value
Normal Coronaries
(n ¼ 4,829)
Nonnormal Coronaries
(n ¼ 17,709)
Demographics
Age, yrs 61.8 (57.2–66.9) 58.3 (51.2–62.7) 62.5 (58.7–68.2) <0.001
Male 21,548 (95.6) 4,313 (89.3) 17,235 (97.3) <0.001
White 16,937 (75.1) 3,252 (67.3) 13,685 (77.3) <0.001
Risk factors and comorbidities
History of smoking 12,836 (57.0) 2,582 (53.5) 10,254 (57.9) <0.001
Diabetes 9,073 (40.3) 1,486 (30.8) 7,587 (42.8) <0.001
Hypertension 19,534 (86.7) 3,802 (78.7) 15,732 (88.8) <0.001
Hyperlipidemia 18,155 (80.6) 3,438 (71.2) 14,717 (83.1) <0.001
Cholesterol, mg/dl 170 (145–199) 172 (148–200) 169 (145–199) <0.001
HDL, mg/dl 38 (32–46) 39 (33–47) 38 (32–45) <0.001
LDL, mg/dl 98 (78–120) 100 (81–121) 97 (77–120) <0.001
Peripheral vascular disease 3,084 (13.7) 306 (6.3) 2,778 (15.7) <0.001
Cerebrovascular disease 2,577 (11.4) 326 (6.8) 2,251 (12.7) <0.001
Congestive heart failure 1,969 (8.7) 356 (7.4) 1,613 (9.1) <0.001
Obese 10,037 (44.5) 2,355 (48.8) 7,682 (43.4) <0.001
Overweight 4,092 (18.2) 761 (15.8) 3,331 (18.8) <0.001
Chronic obstructive pulmonary disease 4,210 (18.7) 838 (17.4) 3,372 (19.0) <0.01
GFR, ml/min/1.73 m2 77.4 (65.8–90.7) 80.5 (69.1–93.8) 77.4 (65–90) <0.001
Renal failure 1,288 (5.7) 194 (4.0) 1,094 (6.2) <0.001
Dialysis 325 (1.4) 59 (1.2) 266 (1.5) 0.15
Framingham risk
Low 4,773 (21.2) 1,810 (37.5) 2,963 (16.7)
Intermediate 9,125 (40.5) 1,963 (40.7) 7,162 (40.4) <0.001
High 8,640 (38.3) 1,056 (21.9) 7,584 (42.8)
Noninvasive test
Performed 16,914 (75.0) 3,396 (70.3) 13,518 (76.3) <0.01
Noninvasive result when performed
Positive 7,798 (46.1) 1,466 (43.2) 6,332 (46.8)
Negative 865 (5.1) 229 (6.7) 636 (4.7) <0.001
Equivocal 643 (3.8) 203 (6.0) 440 (3.3)
Unknown 7,608 (45.0) 1,498 (44.1) 6,110 (45.2)
Procedural indication*
Typical angina 5,639 (25.0) 915 (18.9) 4,724 (26.7) <0.001
Atypical chest pain 15,438 (68.5) 3,488 (72.2) 11,950 (67.5) <0.001
Ischemic heart disease 2,279 (10.1) 115 (2.4) 2,164 (12.2) <0.001
Positive functional study 14,548 (64.5) 2,900 (60.1) 11,648 (65.8) <0.001
Angiographic ﬁndings
Normal 4,829 (21.4) 4,829 (100)
Obstructive CAD 11,622 (51.6) 11,622 (65.6)
1-vessel CAD 4,394 (19.5) 4,394 (24.8)
2-vessel CAD 3,035 (13.5) 3,035 (17.1)
3-vessel CAD or left main 4,193 (18.6) 4,193 (23.7)
Subsequent revascularization 7,432 (33.0) 7,432 (42.0)
PCI 4,314 (19.1) 4 (0.1) 4,310 (24.3)
CABG 3,118 (13.8) 2 (<0.1) 3,116 (17.6)
Values are median (interquartile range) or n (%). *These categories are not mutually exclusive and percentages may exceed 100%.
CABG ¼ coronary artery bypass graft; CAD ¼ coronary artery disease; GFR ¼ glomerular ﬁltration rate; HDL ¼ high density lipoprotein; LDL ¼ low density
lipoprotein; PCI ¼ percutaneous coronary intervention.
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421Although the CAD risk and rates of normal coronaries in
the VA compared with the U.S. community practice may
represent differences in the clinical threshold for coronary
angiography, it is also possible these ﬁndings simply reﬂect
differences in the population served. Although the medianage of the VA patients undergoing angiography is similar to
that observed in the community practice, the VA population
is predominantly men with a high prevalence of comorbid
conditions. Thus, a higher Framingham risk among patients
undergoing angiography in the VA may reﬂect population
Figure 2
Variation in Hospital Rates of
Normal Coronary Angiography
Normal coronary angiography was deﬁned as angiographic ﬁndings with stenosis
<20% in all vessels. The rate of normal coronaries at Veterans Affairs (VA)
hospitals ranged from 5.5% to 48.5%.
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422differences rather than patient selection. Similarly, if the
prevalence of CAD is higher in the VA than U.S.
community settings, applying the same clinical threshold for
use of coronary angiography may result in a lower normal
coronary rate within the VA. Finally, comparisons of the
pretest likelihood of CAD across practice settings are
complicated by the broad deﬁnition of pre-procedural tests
in prior NCDR studies and high rates of missing stress test
results in the VA (5).
In this VA study, we observed wide variation in facility-
level measures of patient selection for angiography that
mirrors variation in the U.S. community practice (6). Some
have suggested that integrated and salaried care delivery
systems may mitigate variation in care delivery related to
monetary reimbursement for coronary procedures and supply
related issues of excessive catheterization facilities or invasive
cardiologists (7–9). Thus, the remaining facility-level vari-
ation may speak to other factors that impede consistent and
guideline-concordant patient selection for coronary proce-
dures. For example, catheterization facilities may be inﬂu-
enced by procedural volume thresholds, local practice
patterns, liability concerns of misdiagnosis, and the expec-
tations of referring providers in the performance of diag-
nostic angiography (18). This may include proceeding to
angiography in the absence of pre-procedural stress testing
to reﬁne the likelihood of CAD. In addition, prior studies
suggest regionalization of cardiac procedural care raises the
clinical threshold for proceeding to coronary angiography
among patients referred from nonprocedural facilities (19).
Finally, the expectations of patients and their family to
pursue invasive testing may inﬂuence the decision to pursue
coronary angiography (18). Further investigation is critical
to elucidate the factors that contribute to suboptimal pati-
ent selection within the VA, as this may lead to strategies
that complement care integration and reimbursement rede-
sign in the effective and efﬁcient delivery of medical and
procedural care.Although normal coronary rates indirectly reﬂect patient
selection, this measure lacks a quality improvement target to
support proper patient selection, and the optimal rate of
normal coronaries is unknown. As a result, it is unclear if the
lower normal coronary rate in the VA, as compared with
other U.S. hospitals, reﬂects relative procedural underuse
from overly restrictive patient selection in the VA or po-
tential overuse in community practice. Furthermore, in
comparing a hospital’s patient selection proﬁle, we demon-
strated the choice of stenosis threshold has important
implications on a hospital’s performance rank. For example,
the use of rates of nonobstructive CAD rather than normal
coronary rates changed the hospital rank by more than 25%
for nearly 2 in 5 hospitals. This suggests a single angiogra-
phic measure of patient selection quality may lack adequate
precision as a performance benchmark.
As an alternative to normal coronary rates, pre-procedural
measures of patient selection may afford avenues for quality
improvement. For example, the consistent assessment of
pre-procedural risk of signiﬁcant CAD has been suggested
as an approach to ensure proper patient selection (20). In
our study, higher use of pre-procedural stress testing at
hospitals with lower rates of normal coronaries suggests the
potential beneﬁt of a patient selection strategy emphasizing
CAD risk. However, this approach fails to consider the
treatment implications of the angiographic ﬁndings for
highly symptomatic patients when pre-procedural assess-
ment of CAD risk is low (21). Furthermore, greater use of
stress testing among patients with a low-likelihood of CAD
may inadvertently lead to higher rates of normal coronary
angiography due to diagnostic evaluation of false-positive
tests (22,23). An alternative approach integrates patient
symptoms, global CAD risk, stress test ﬁndings, and the
implications of the angiographic results in determining the
procedural indication. Recently published Appropriate Use
Criteria (AUC) for diagnostic coronary angiography guide-
lines apply this procedural indication framework and may
support high quality selection for angiography through
identiﬁcation of patients in which the procedural risk
outweighs the potential diagnostic beneﬁt (2). Future
updates to CART data elements and improved capture of
ischemic risk from stress tests results may allow imple-
mentation of the AUC framework in assessing procedural
indication. However, there are potential shortcomings to
the AUC as stand-alone quality measures. As providers
become increasingly aware of the clinical determinants of the
AUC, physicians may be motivated to “upcode” aspects of
the patient’s pre-procedural assessment to inﬂuence apparent
appropriateness. Efforts to improve standardized reporting
of noninvasive stress test results and patient-centered
assessment of symptom status (e.g., Seattle Angina Ques-
tionnaire) may address these potential shortcomings. In
the end, procedural indication metrics, such as the AUC,
may need to be balanced by normal coronary angiography
rates to ensure validity in quality comparisons between
facilities.
Table 2 Patient Characteristics by Hospital Quartile of Normal Coronary Rates
Patient Characteristics
Hospital Quartile of Normal Coronary Rates
p Value
1 (Lowest)
(n ¼ 4,515)
2
(n ¼ 6,398)
3
(n ¼ 6,197)
4 (Highest)
(n ¼ 5,428)
Hospital median proportion of normal coronaries, % 10.8 (9.5–13.7) 19.1 (17.6–19.7) 23.1 (22–23.6) 30.3 (26.8–36)
Hospital range of normal coronaries, % 5.5–15.1 16.2–20.5 20.5–25.3 25.4–48.5
Demographics
Age, yrs 62.0 (57.7–67.2) 61.7 (57.1–67) 61.6 (56.7–66.6) 61.8 (57.2–66.8) 0.006
Male, % 4,332 (95.9) 6,130 (95.8) 5,912 (95.4) 5,174 (95.3) 0.31
White, % 3,357 (74.4) 4,836 (75.6) 4,613 (74.4) 4,131 (76.1) 0.09
Risk factors and comorbidities
History of smoking 2,392 (53.0) 3,794 (59.3) 3,315 (53.5) 3,335 (61.4) <0.001
Diabetes 1,837 (40.7) 2,552 (39.9) 2,434 (39.3) 2,250 (41.5) 0.09
Hypertension 3,918 (86.8) 5,631 (88.0) 5,292 (85.4) 4,693 (86.5) <0.001
Hyperlipidemia 3,611 (80.0) 5,227 (81.7) 4,882 (78.8) 4,435 (81.7) <0.001
Cholesterol, mg/dl 171 (147–201) 170 (145–199) 169 (144–198) 169 (145–197) 0.009
HDL 39 (33–46) 38 (32–46) 38.0 (32–46) 38 (32–46) <0.001
LDL 98 (78–121) 97 (78–120) 97 (77–120) 98 (78–120) 0.84
Peripheral vascular disease 594 (13.2) 939 (14.7) 840 (13.6) 711 (13.1) 0.04
Cerebrovascular disease 489 (10.8) 763 (11.9) 688 (11.1) 637 (11.7) 0.23
Congestive heart failure 408 (9.0) 562 (8.8) 500 (8.1) 499 (9.2) 0.14
Obese 1,968 (43.6) 2,954 (46.2) 2,664 (43.0) 2,451 (45.2) 0.002
Overweight 783 (17.3) 1,330 (20.8) 948 (15.3) 1,031 (19.0) <0.001
Chronic obstructive pulmonary disease 809 (17.9) 1,229 (19.2) 1,197 (19.3) 975 (18.0) 0.09
GFR, ml/min/1.73 m2 77.4 (63.2–90) 78.0 (66.4–91.5) 77.4 (67–90) 77.4 (65.8–90.7) <0.001
Renal failure 267 (5.9) 387 (6.0) 349 (5.6) 285 (5.3) 0.27
Dialysis 65 (1.4) 109 (1.7) 83 (1.3) 68 (1.3) 0.19
Clinical presentation
Framingham risk
Low 941 (20.8) 1,325 (20.7) 1,390 (22.4) 1,117 (20.6) <0.001
Intermediate 1,877 (41.6) 2,498 (39.0) 2,545 (41.1) 2,205 (40.6)
High 1,697 (37.6) 2,575 (40.2) 2,262 (36.5) 2,106 (38.8)
Noninvasive testing
Performed 3,590 (79.5) 4,956 (77.5) 4,805 (77.5) 3,563 (65.6) <0.01
Noninvasive result when performed
Positive 1,600 (44.6) 2,318 (46.8) 2,276 (47.4) 1,604 (45.0) <0.001
Negative 191 (5.3) 316 (6.4) 207 (4.3) 151 (4.2)
Equivocal 147 (4.1) 210 (4.2) 146 (3.0) 140 (3.9)
Unknown 1,652 (47.1) 2,112 (42.6) 2,176 (45.3) 1,668 (46.8)
Procedural indication*
Typical angina 1,230 (27.2%) 1,522 (23.8%) 1,632 (26.3%) 1,255 (23.1%) <0.001
Atypical chest pain 2,987 (66.2%) 4,452 (69.6%) 4,177 (67.4%) 3,822 (70.4%) <0.001
Ischemic heart disease 694 (15.4%) 524 (8.2%) 528 (8.5%) 533 (9.8%) <0.001
Positive functional study 3,022 (66.9%) 4,220 (66.0%) 4,114 (66.4%) 3,192 (58.8%) <0.001
Angiographic ﬁndings
Normal 515 (11.4) 1,185 (18.5) 1,415 (22.8) 1,714 (31.6) <0.001
Obstructive CAD 2,675 (59.2) 3,284 (51.3) 3,261 (52.6) 2,402 (44.3)
1-vessel CAD 1,017 (22.5) 1,246 (19.5) 1,232 (19.9) 899 (16.6)
2vessel CAD 669 (14.8) 869 (13.6) 855 (13.8) 642 (11.8)
3-vessel CAD or left main 989 (21.9) 1,169 (18.3) 1,174 (18.9) 861 (15.9)
Subsequent revascularization 1,721 (38.1) 2168 (33.9) 1,951 (31.5) 1,592 (29.3) <0.001
PCI 993 (22.0) 1,281 (20.0) 1,166 (18.8) 874 (16.1) <0.001
CABG 728 (16.1) 887 (13.9) 785 (12.7) 718 (13.2) <0.001
Values are median (interquartile range) or n (%). *Categories not mutually exclusive and percentages may exceed 100%.
Abbreviations as in Table 1.
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423Study limitations. First, we are unable to identify stress
tests performed outside the VA that are not captured by
Medicare. In addition, the speciﬁc results of stress tests (e.g.,amount and distribution of ischemia) were unknown for
a large number of patients. Thus, we were able to evaluate
whether a stress test was done in the VA prior to elective
Figure 3 Facility-Level Variation in Angiographic Results by Varying Cut Points
(A) Graph showing the hospital rate of nonobstructive disease by rate of normal coronaries. The correlation between the hospital rate of normal coronaries and the hospital rate
of nonobstructive coronary artery disease (CAD) (Pearson rho ¼ 0.63; p < 0.001). (B) Graph showing the hospital rank of nonobstructive disease by rank of normal coronaries.
Using nonobstructive coronary rates rather than normal coronary rates resulted in nearly 2 in 5 hospitals changing rank by more than 25% (boundaries marked by dashed lines).
The rank improved for 12 hospitals (green triangles) and worsened for 13 hospitals (red circles). Hospital change in rank was <25% for 41 hospitals (blue squares).
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424cardiac catheterization, but we were not able to evaluate the
association between speciﬁc stress test results and rates of
normal coronary angiography. This limitation is noted in
prior studies of patient selection for invasive coronary
procedures in other care delivery settings and is a target for
future research (24,25). Second, we lacked quality data on
patient symptom burden, a key component to clinical indi-
cation and pre-procedural likelihood of CAD (26–28). This
is an additional target for future research. Third, some inva-
sive cardiologists may not be fully salaried within the VA
system because of dual appointments with academic centers;
however, we lack data to identify these providers. Under-
standing whether providers who work in both VA and non-
VA settings are associated with differences in patientTable 3 Hospital Characteristics by Hospital Quartile of Normal Coro
Hospital Characteristics
All Hospitals
(N ¼ 66)
1 (Lowest)
(n ¼ 17)
Median proportion of normal coronaries, % 20.5 (15.1–25.3) 10.8 (9.5–13.7)
Range of normal coronaries, % 5.5–48.5 5.5–15.1
Operating beds 151 (108–216) 126 (93–199)
Annual coronary angiography volume 548 (395–744) 448 (378–588)
Annual PCI volume 180 (133–248) 180 (124–252)
CT surgery on-site 39 (59.1) 12 (30.8)
Teaching facility 52 (78.8) 15 (88.2)
Geographic region
Midwest 19 (28.8) 6 (35.3)
Northeast 5 (7.6) 1 (5.9)
South 28 (42.4) 5 (29.4)
West 14 (21.2) 5 (29.4)
Values are median (interquartile range) or n (%).
CT ¼ cardiothoracic; other abbreviations as in Table 1.selection and procedural use is an important area for future
research. Fourth, despite the use of all available data in
assessing angiographic results of elective diagnostic coronary
angiography, we cannot exclude the possibility of misclas-
siﬁcation of angiographic ﬁndings. This is suggested by the
6 patients who underwent revascularization in the 90 days
following normal coronary angiography. Finally, there is
broad interobserver variation in the interpretation of coro-
nary angiograms (1,29). However, our analyses on rates of
nonobstructive CAD, obstructive CAD, and subsequent
revascularization suggest that the observed variation in
normal coronary rates reﬂect differences in patient selection,
rather than variation in provider interpretation of the
angiogram.nary Rates
Hospital Quartile of Normal Coronary Rates
p Value
2
(n ¼ 16)
3
(n ¼ 17)
4 (Highest)
(n ¼ 16)
19.1 (17.6–19.7) 23.1 (22–23.6) 30.3 (26.8–36)
16.2–20.5 20.5–25.3 25.4–48.5
151 (106–236) 165 (129–216) 146 (114–244) 0.76
644 (431–846.5) 581 (408–744) 501 (330–689) 0.28
199 (168–312) 178 (129–235) 149 (117–217) 0.39
9 (23.1) 10 (25.6) 8 (20.5) 0.27
14 (87.5) 14 (82.4) 9 (56.3) 0.03
4 (25.0) 6 (35.3) 3 (18.8)
1 (6.3) 2 (11.8) 1 (6.3) 0.85
9 (56.3) 6 (35.3) 8 (50.0)
2 (12.5) 3 (17.6) 4 (25.0)
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425Conclusions
Among patients undergoing elective coronary angiography
in the VA, approximately 1 in 5 patients had normal coro-
naries. This is a lower average rate of normal coronaries as
compared with previous ﬁndings from other U.S. hospitals.
However, we observed wide hospital level variation in
normal coronary rates in the VA. Thus, although there may
be a higher clinical threshold to select patients for coronary
angiography in the integrated healthcare system of the VA,
barriers to consistent patient selection for invasive coronary
procedures are present in both the integrated healthcare
setting of the VA and fee-for-service healthcare systems.
Without addressing these barriers, healthcare reform efforts
to improve integration and reduce fee-for-service care may
be insufﬁcient to optimize patient selection for procedural
care. Future emphasis on procedural indication, with
ongoing monitoring of normal coronary rates as an indirect
measure of effect, may assist quality improvement efforts to
achieve consistent patient selection as a part of high quality
care.
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